[HIV: less resistance due to combined treatment].
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000494:pharmacology*; D003196:Computer Graphics; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006678:HIV / Q000187:drug effects* / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy*; D016333:HIV Protease; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D019259:Lamivudine / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors; D015215:Zidovudine / Q000008:administration & dosage / Q000494:pharmacology
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D016333:HIV Protease